What are the primary orders to document for a 53-year-old male on pressure‑assist‑control ventilation, including ventilator settings, sedation, analgesia, DVT prophylaxis, stress‑ulcer prophylaxis, insulin infusion, and monitoring?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Primary Chart Orders for 53-Year-Old Male on Pressure-Assist-Control Ventilation

For a 53-year-old male requiring pressure-assist-control ventilation, document the following core orders: ventilator mode (assist-control with pressure-targeted settings), tidal volume 6-8 mL/kg ideal body weight, respiratory rate 10-15 breaths/min, PEEP individualized (typically 5-10 cmH₂O), FiO₂ titrated to SpO₂ 88-92% (or 94-98% if no hypercapnia risk), plateau pressure limit <30 cmH₂O; sedation with opioid infusion (fentanyl) titrated to comfort plus benzodiazepine (midazolam) or propofol as needed; DVT prophylaxis with pharmacologic agent unless contraindicated; stress ulcer prophylaxis with H2-receptor antagonist or PPI; insulin infusion protocol if hyperglycemic; and continuous monitoring of SpO₂, ETCO₂, airway pressures, and vital signs. 1, 2, 3

Ventilator Settings

Mode and Basic Parameters

  • Mode: Assist-control (volume-cycled or pressure-regulated) 1

    • Provides complete ventilatory support initially
    • Allows patient triggering while maintaining mandatory backup rate
  • Tidal Volume: 6-8 mL/kg ideal body weight 2, 4

    • Calculate ideal body weight: Men = 50 + 2.3 × (height in inches - 60)
    • Lower end (6 mL/kg) preferred to prevent ventilator-induced lung injury
  • Respiratory Rate: 10-15 breaths/min for obstructive disease; 15-25 for neuromuscular conditions 2

    • Adjust based on underlying pathology
    • Allow sufficient expiratory time to prevent auto-PEEP
  • Inspiratory:Expiratory Ratio: 1:2 to 1:4 for obstructive disease; 1:1 to 1:2 for restrictive conditions 2

    • Prolonged expiratory time limits gas trapping in obstructive disease

Pressure Targets

  • Plateau Pressure: Maintain <30 cmH₂O 1, 2, 4

    • This is the critical safety threshold to prevent alveolar overdistension
    • Monitor continuously; adjust tidal volume downward if exceeded
  • Driving Pressure: Monitor (Plateau pressure - PEEP) 4

    • Lower driving pressures associated with better outcomes
    • Document and trend this value

Oxygenation Strategy

  • FiO₂: Titrate to target SpO₂ 1, 5

    • Target SpO₂ 88-92% if risk factors for hypercapnia (COPD, obesity, neuromuscular disease) 5
    • Target SpO₂ 94-98% if no hypercapnia risk and normal PCO₂ 5
    • Avoid unnecessary hyperoxia
  • PEEP: Individualize, typically 5-10 cmH₂O 1, 2

    • Apply PEEP to prevent alveolar collapse and improve oxygenation
    • Higher PEEP (up to 15 cmH₂O) may be needed in ARDS
    • In obstructive disease, keep PEEP modest to avoid worsening hyperinflation
    • Titrate based on oxygenation response and hemodynamic tolerance

Permissive Hypercapnia

  • pH Target: ≥7.2 2
    • Accept elevated PCO₂ to avoid dangerous airway pressures
    • Contraindicated if increased intracranial pressure or severe cardiac dysfunction
    • More permissive targets acceptable in chronic hypercapnia (infer from elevated bicarbonate)

Sedation and Analgesia

Opioid Analgesia (First-Line)

  • Fentanyl infusion: Start 25-50 mcg/h 6, 3
    • Bolus: Give hourly infusion rate as bolus every 5 minutes PRN for breakthrough pain/dyspnea 6
    • Titrate: Double infusion rate if 2 boluses needed within 1 hour 6
    • Rationale: Treat pain and respiratory distress first before adding sedatives 6

Sedation (Second-Line, After Analgesia)

  • Option 1 - Midazolam: Start 1 mg/h infusion 6

    • Bolus: 1-2 mg IV every 5 minutes PRN for agitation 6
    • Titrate: Double infusion if 2 boluses needed within 1 hour 6
  • Option 2 - Propofol: Alternative to benzodiazepines 6, 3

    • Start 5-10 mcg/kg/min, titrate to effect
    • Monitor for propofol infusion syndrome with prolonged use
  • Sedation Target: Light sedation allowing patient-ventilator synchrony 3

    • Use sedation scoring (RASS -2 to 0 typically appropriate)
    • Avoid deep sedation unless specifically indicated
    • Critical: Sedatives only after pain/dyspnea controlled with opioids 6

Monitoring Sedation

  • Assess and document sedation level every 2-4 hours using validated scale (RASS, SAS)
  • Daily sedation interruption or lightening to assess neurologic status and readiness for weaning 3
  • Monitor for delirium using CAM-ICU 6

DVT Prophylaxis

Pharmacologic prophylaxis unless contraindicated 3:

  • Enoxaparin 40 mg subcutaneous daily, OR
  • Heparin 5,000 units subcutaneous every 8-12 hours
  • Add sequential compression devices for additional mechanical prophylaxis
  • Contraindications: Active bleeding, severe thrombocytopenia, recent neurosurgery

Stress Ulcer Prophylaxis

H2-receptor antagonist or proton pump inhibitor 7:

  • Famotidine 20 mg IV every 12 hours, OR
  • Pantoprazole 40 mg IV daily
  • H2-receptor antagonists are standard of care for mechanically ventilated patients 7
  • Continue while intubated and on mechanical ventilation

Insulin Management

  • Insulin infusion protocol if blood glucose >180 mg/dL
  • Target glucose 140-180 mg/dL in critically ill patients
  • Monitor blood glucose every 1-2 hours initially, then every 4 hours when stable
  • Avoid hypoglycemia (<70 mg/dL)

Monitoring Orders

Continuous Monitoring

  • Pulse oximetry (SpO₂) 8, 5
  • End-tidal CO₂ (ETCO₂) if available
  • Cardiac monitoring (telemetry)
  • Arterial line for continuous blood pressure and arterial blood gas sampling (strongly recommended)

Ventilator Parameters to Document

  • Dynamic compliance 4
  • Plateau pressure (measure with inspiratory hold) 4
  • Driving pressure (Plateau - PEEP) 4
  • Auto-PEEP (measure with expiratory hold if suspected)
  • Peak inspiratory pressure
  • Minute ventilation

Intermittent Assessments

  • Arterial blood gas: 30-60 minutes after ventilator changes, then every 4-6 hours or as clinically indicated 5
  • Chest X-ray: Daily or after ventilator changes/clinical deterioration
  • Vital signs: Every 1-4 hours depending on stability
  • Ventilator synchrony assessment: Document patient-ventilator interaction, trigger efforts, and any dyssynchrony

Additional Supportive Orders

  • Head of bed elevation 30-45 degrees (aspiration prevention, VAP prevention)
  • Oral care with chlorhexidine every 12 hours (VAP prevention)
  • Nutrition: Enteral feeding via orogastric/nasogastric tube (start within 24-48 hours if hemodynamically stable)
  • Skin care: Turn every 2 hours, pressure ulcer prevention
  • Eye care: Artificial tears, eye protection if sedated

Emergency Equipment/Medications

Document availability of:

  • Reversal agents immediately available 8:
    • Naloxone for opioid reversal
    • Flumazenil for benzodiazepine reversal
  • Airway equipment: Suction, bag-valve-mask, emergency intubation supplies 8
  • Resuscitation medications and defibrillator 8

Key Monitoring Pitfalls to Avoid

  1. Do not target normal PCO₂ if plateau pressures exceed 30 cmH₂O—accept permissive hypercapnia with pH ≥7.2 2
  2. Do not use excessive tidal volumes (>8 mL/kg IBW)—this causes ventilator-induced lung injury 1, 2
  3. Do not add sedatives before treating pain—opioids first, then sedatives only if needed 6
  4. Do not target excessive oxygenation—SpO₂ 88-92% is adequate for most patients with hypercapnia risk 5
  5. Monitor for auto-PEEP in obstructive disease—prolonged expiratory time and lower respiratory rates prevent gas trapping 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.